Glossaire sclérose en plaques
:quality(90)/)
Sources :
MS Society UK. NEDA (no evidence of disease activity). Available at
Accessed September 2016. Lublin FD, et al. Defining the clinical course of multiple sclerosis. Neurology. 2014; 83(3):278 – 86.
Wiendl H, Meuth SG. Pharmacological Approaches to Delaying Disability Progression in Patients with Multiple Sclerosis. Drugs. 2015;75(9):947-977.
Giovannoni, G, et al. Brain Health: Time Matters in Multiple Sclerosis. 2015; pp 14.
National MS Society. Magnetic Resonance Imaging (MRI). Available at
Accessed September 2016. National MS Society. Functional Systems Score (FSS) and Expanded Disability Status Scale. Available at
Accessed September 2016. Fisher et al. Gray Matter Atrophy in Multiple Sclerosis: A Longitudinal study. Ann Neurol 2008;64:255–265 - Fisniku et al. Gray matter atrophy is related to long-term disability in multiple sclerosis. Ann Neurol 2008 64: 247-54 - Fisher et al. Relationship between brain atrophy and disability: an 8-year follow-up study of multiple sclerosis patients. Multiple Sclerosis 2000; 6, 373-377.
National MS Society. Multiple Sclerosis Functional Composite (MSFC). Available at
Accessed September 2016. National MS Society. Paced Auditory Serial Addition Test (PASAT). Available at
Accessed September 2016. National MS Society. Timed 25-Foot Walk (T25-FW). Available at
Accessed September 2016. National MS Society. 9-Hole Peg Test (9-HPT). Available at
Accessed September 2016.
M-FR-00009522-1.0 - Établi en septembre 2023